Literature DB >> 20435626

Transcriptional silencing of the ETS1 oncogene contributes to human granulocytic differentiation.

Valentina Lulli1, Paolo Romania, Roberta Riccioni, Alessandra Boe, Francesco Lo-Coco, Ugo Testa, Giovanna Marziali.   

Abstract

BACKGROUND: Ets-1 is a widely expressed transcription factor implicated in several biological processes including hematopoiesis, where it contributes to the regulation of cellular differentiation. The functions of Ets-1 are regulated by transcription factors as well as by phosphorylation events: phosphorylation of threonine 38 activates Ets-1, whereas phosphorylation of a cluster of serines within exon VII reduces DNA binding activity. This study focuses on the role of Ets-1 during granulocytic differentiation of NB4 promyelocytic and HL60 myeloblastic leukemia cell lines induced by all-trans retinoic acid. DESIGN AND METHODS: Ets-1 expression was measured by real-time reverse transcriptase polymerase chain reaction and western blotting. The role of Ets-1 during all-trans retinoic acid-induced differentiation was analyzed by using a transdominant negative molecule or small interfering RNA.
RESULTS: NB4 and HL60 cell lines expressed high levels of p51 Ets-1, while the splice variant isoform that lacks exon VII (p42) was almost undetectable. The addition of all-trans retinoic acid reduced p51 Ets-1 levels and induced inhibitory phosphorylation of the remaining protein. Expression of Ets-1 was also reduced during dimethylsulfoxide-induced differentiation and during granulocytic differentiation of human CD34(+) hematopoietic progenitor cells but not in NB4.R2 and HL60R cells resistant to all-trans retinoic acid. In line with these observations, transduction of a transdominant negative molecule of Ets-1, which inhibited DNA binding and transcriptional activity of the wild-type Ets-1, significantly increased chemical-induced differentiation. Consistently, Ets-1 knockdown by small interfering RNA increased the number of mature neutrophils upon addition of all-trans retinoic acid. Interestingly, p51 Ets-1 over-expression was frequently observed in CD34(+) hematopoietic progenitor cells derived from patients with acute myeloid leukemia, as compared to its expression in normal CD34(+) cells.
CONCLUSIONS: Our results indicated that a decreased expression of Ets-1 protein generalizes to granulocytic differentiation and may represent a crucial event for granulocytic maturation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20435626      PMCID: PMC2948087          DOI: 10.3324/haematol.2010.023267

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  37 in total

1.  Hemoglobin switching in unicellular erythroid culture of sibling erythroid burst-forming units: kit ligand induces a dose-dependent fetal hemoglobin reactivation potentiated by sodium butyrate.

Authors:  M Gabbianelli; U Testa; A Massa; E Pelosi; N M Sposi; R Riccioni; L Luchetti; C Peschle
Journal:  Blood       Date:  2000-06-01       Impact factor: 22.113

2.  Expression of the ets-1 proto-oncogene in human colorectal carcinoma.

Authors:  T Nakayama; M Ito; A Ohtsuru; S Naito; I Sekine
Journal:  Mod Pathol       Date:  2001-05       Impact factor: 7.842

3.  Structural analysis of the autoinhibition of Ets-1 and its role in protein partnerships.

Authors:  Colin W Garvie; Miles A Pufall; Barbara J Graves; Cynthia Wolberger
Journal:  J Biol Chem       Date:  2002-09-06       Impact factor: 5.157

4.  Isoforms of the human ets-1 protein: generation by alternative splicing and differential phosphorylation.

Authors:  S Koizumi; R J Fisher; S Fujiwara; C Jorcyk; N K Bhat; A Seth; T S Papas
Journal:  Oncogene       Date:  1990-05       Impact factor: 9.867

5.  Combinations of retinoic acid with either sodium butyrate, dimethyl sulfoxide, or hexamethylene bisacetamide synergistically induce differentiation of the human myeloid leukemia cell line HL60.

Authors:  T R Breitman; R Y He
Journal:  Cancer Res       Date:  1990-10-01       Impact factor: 12.701

6.  An ERK2 docking site in the Pointed domain distinguishes a subset of ETS transcription factors.

Authors:  Jeffrey J Seidel; Barbara J Graves
Journal:  Genes Dev       Date:  2002-01-01       Impact factor: 11.361

7.  Angiogenesis inhibition by transdominant mutant Ets-1.

Authors:  T Nakano; M Abe; K Tanaka; R Shineha; S Satomi; Y Sato
Journal:  J Cell Physiol       Date:  2000-08       Impact factor: 6.384

Review 8.  ETS transcription factors: possible targets for cancer therapy.

Authors:  Tsuneyuki Oikawa
Journal:  Cancer Sci       Date:  2004-08       Impact factor: 6.716

9.  Enhancement of ATRA-induced cell differentiation by inhibition of calcium accumulation into the endoplasmic reticulum: cross-talk between RAR alpha and calcium-dependent signaling.

Authors:  Sophie Launay; Maurizio Giannì; Luisa Diomede; Laura M Machesky; Jocelyne Enouf; Béla Papp
Journal:  Blood       Date:  2002-12-19       Impact factor: 22.113

Review 10.  The biology of the Ets1 proto-oncogene.

Authors:  Jürgen Dittmer
Journal:  Mol Cancer       Date:  2003-08-20       Impact factor: 27.401

View more
  10 in total

1.  Negative regulation of cyclin D3 expression by transcription factor c-Ets1 in umbilical cord hematopoietic cells.

Authors:  Fan-kai Meng; Han-ying Sun; Xi-you Tan; Chun-rui Li; Jian-feng Zhou; Wen-li Liu
Journal:  Acta Pharmacol Sin       Date:  2011-08-15       Impact factor: 6.150

2.  The analysis of novel distal Cebpa enhancers and silencers using a transcriptional model reveals the complex regulatory logic of hematopoietic lineage specification.

Authors:  Eric Bertolino; John Reinitz
Journal:  Dev Biol       Date:  2016-03-03       Impact factor: 3.582

3.  Constitutive activation of the ETS-1-miR-222 circuitry in metastatic melanoma.

Authors:  Gianfranco Mattia; M Cristina Errico; Federica Felicetti; Marina Petrini; Lisabianca Bottero; Luisa Tomasello; Paolo Romania; Alessandra Boe; Patrizia Segnalini; Antonio Di Virgilio; Mario P Colombo; Alessandra Carè
Journal:  Pigment Cell Melanoma Res       Date:  2011-10       Impact factor: 4.693

4.  Human TM9SF4 Is a New Gene Down-Regulated by Hypoxia and Involved in Cell Adhesion of Leukemic Cells.

Authors:  Rosa Paolillo; Isabella Spinello; Maria Teresa Quaranta; Luca Pasquini; Elvira Pelosi; Francesco Lo Coco; Ugo Testa; Catherine Labbaye
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

5.  Ets1 Plays a Critical Role in MLL/EB1-Mediated Leukemic Transformation in a Mouse Bone Marrow Transplantation Model.

Authors:  Jen-Fen Fu; Tzung-Hai Yen; Ying-Jung Huang; Lee-Yung Shih
Journal:  Neoplasia       Date:  2019-04-08       Impact factor: 5.715

6.  High expression of miR-363 predicts poor prognosis and guides treatment selection in acute myeloid leukemia.

Authors:  Huihui Zhang; Ninghan Zhang; Rong Wang; Tingting Shao; Yuan Feng; Yao Yao; Qingyun Wu; Shengyun Zhu; Jiang Cao; Huanxin Zhang; Zhenyu Li; Xuejiao Liu; Mingshan Niu; Kailin Xu
Journal:  J Transl Med       Date:  2019-04-01       Impact factor: 5.531

7.  The small-molecule compound AC-73 targeting CD147 inhibits leukemic cell proliferation, induces autophagy and increases the chemotherapeutic sensitivity of acute myeloid leukemia cells.

Authors:  Isabella Spinello; Ernestina Saulle; Maria Teresa Quaranta; Luca Pasquini; Elvira Pelosi; Germana Castelli; Tiziana Ottone; Maria Teresa Voso; Ugo Testa; Catherine Labbaye
Journal:  Haematologica       Date:  2018-11-22       Impact factor: 9.941

8.  Lymphoid enhancer binding factor-1 (LEF1) expression as a prognostic factor in adult acute promyelocytic leukemia.

Authors:  Francesco Albano; Antonella Zagaria; Luisa Anelli; Paola Orsini; Crescenzio Francesco Minervini; Luciana Impera; Paola Casieri; Nicoletta Coccaro; Giuseppina Tota; Claudia Brunetti; Angela Minervini; Domenico Pastore; Paola Carluccio; Anna Mestice; Angelo Cellamare; Giorgina Specchia
Journal:  Oncotarget       Date:  2014-02-15

9.  The impact of Mir-9 regulation in normal and malignant hematopoiesis.

Authors:  Abbas Khosravi; Shaban Alizadeh; Arsalan Jalili; Reza Shirzad; Najmaldin Saki
Journal:  Oncol Rev       Date:  2018-03-27

Review 10.  The Role of Interferon-Gamma in Hematopoietic Stem Cell Development, Homeostasis, and Disease.

Authors:  Daniel E Morales-Mantilla; Katherine Y King
Journal:  Curr Stem Cell Rep       Date:  2018-07-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.